Fierce Pharma

MARCH 29, 2024

Bristol Myers Squibb’s Zeposia (ozanimod) has attracted attention as a treatment for an unusual duo of diseases—multiple sclerosis (MS) and ulcerative colitis (UC). | Bristol Myers Squibb’s Zeposia has attracted attention as a treatment for an odd pair of unrelated diseases—multiple sclerosis (MS) and ulcerative colitis (UC). But the approval roll for the sphingosine 1-phosphate (S1P) receptor modulator may be over.

266

266

MedCity News

MARCH 29, 2024

Labcorp is buying the clinical diagnostics and reproductive women’s health businesses of BioReference Health, excluding those assets in New York and New Jersey. Labcorp has returned to being fully focused on lab-testing after last year’s spinoff of Fortrea, its former clinical trial services business.

Biopharma 105

Biopharma 105

Fierce Pharma

MARCH 29, 2024

Bristol Myers Squibb looks on track to overtake Amgen as the KRAS leader in lung cancer after following up its rival’s FDA setback with a positive confirmatory trial readout. | Bristol Myers Squibb looks on track to overtake Amgen as the KRAS leader in lung cancer after following up its rival’s FDA setback with a positive confirmatory trial readout.

FDA 261

FDA 261

Pharmaceutical Commerce

MARCH 29, 2024

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses the specific factors contributing to rising manufacturing costs.

Manufacturing 104

Manufacturing Biopharma Leads Pharmaceutical 104

Advertisement

Distribution

Fierce Pharma

MARCH 29, 2024

Once again, a medicine in the popular GLP-1 class of diabetes and weight loss therapies is facing supply hurdles. | While the drug is not listed on the FDA's shortage list, some pharmacies are facing supply issues. Amazon Pharmacy, for instance, notes that several dosage strengths are "unavailable.

Medicine 247

Medicine FDA 247

MedCity News

MARCH 29, 2024

A new report from Ernst & Young revealed that healthcare organizations are seeing financial benefits and improved outcomes from their health equity strategies.

Healthcare 101

Healthcare Healthcare 101

PharmaTech

MARCH 29, 2024

FDA has approved AstraZeneca's Ultomiris, marking the first and only long-acting C5 complement inhibitor for patients with NMOSD.

FDA 98

FDA Management Patients 98

Fierce Pharma

MARCH 29, 2024

A little more than a year after Hikma Pharmaceuticals accused Amarin of “deliberately and meticulously” hamstringing supplies of the main ingredient in its only marketed drug, Vascepa, to thwart po | A little more than a year after Hikma Pharmaceuticals accused Amarin of “deliberately and meticulously” hamstringing supplies of the main ingredient in its only marketed drug, Vascepa, to thwart potential generic competition, Teva Pharmaceuticals has levied a similar challenge.

Competition 255

Competition Pharmaceutical Marketing 255

MedCity News

MARCH 29, 2024

Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.

Healthcare 105

Healthcare Healthcare 105

pharmaphorum

MARCH 29, 2024

Report claims US intelligence services advised the authors of the BIOSECURE Act that WuXi AppTec shared confidential data on US clients with the Chinese government

Government 81

Government 81

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

MARCH 29, 2024

The conference will be held at the Ritz Carlton hotel in Chicago May 21-22. Space is limited., so secure your spot today to attend!

Healthcare 93

Healthcare Healthcare Biopharma 93

PharmaVoice

MARCH 29, 2024

Rivus’ controlled metabolic accelerators are an emerging new potential competitor to popular weight loss and diabetes drugs from Novo Nordisk and Eli Lilly.

Pharma 64

Pharma 64

MedCity News

MARCH 29, 2024

A healthy and inclusive workplace environment needs flexible solutions that are personalized to all lifestyles, work schedules, cultures and food preferences.

Food 80

Food Patients 80

pharmaphorum

MARCH 29, 2024

Bristol-Myers Squibb's Zeposia has failed to outperform placebo in its first phase 3 test in Crohn's disease

75

75

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

MedCity News

MARCH 29, 2024

Given the increasing competition and rising back-office costs, embracing AI-powered revenue cycle automation to boost profitability and achieve operational excellence is more crucial than ever.

Healthcare Provider 80

Healthcare Provider Healthcare Healthcare Competition 80

Pharmaceutical Commerce

MARCH 29, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma Media 105

MedCity News

MARCH 29, 2024

In this month’s episode, Senior Reporter Katie Adams discussed some executive hires, promotions and departures that recently occurred in the healthcare world, as well as layoffs affecting the industry. We also hear from Brian Anderson, who recently became CEO of the Coalition for Health AI (CHAI).

Healthcare 72

Healthcare Healthcare Biopharma 72

Pharmaceutical Technology

MARCH 29, 2024

Discover how Arvinas Inc's newly granted patent for compounds treating prostate cancer could revolutionize healthcare. Learn more about the potential for new drugs and therapies.

Healthcare 52

Healthcare Healthcare 52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Pharmaceutical Commerce

MARCH 29, 2024

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the hottest therapeutic settings for dealmaking activity at the moment—and one platform approach in particular poised to be at the center of future M&A and licensing pursuits.

Pharmaceutical 52

Pharmaceutical 52

Pharmaceutical Technology

MARCH 29, 2024

Discover the groundbreaking patent by Yield10 Bioscience Inc for a genetically engineered oilseed plant expressing a plant protein, revolutionizing biotechnology in agriculture.

Engineering 52

Engineering 52

PharmExec

MARCH 29, 2024

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.

52

52

Pharmaceutical Technology

MARCH 29, 2024

Discover the innovative dermal patch system by Sun Pharmaceutical Industries Ltd for efficient and minimally invasive physiological sample collection. Patent US11877848B2 revolutionizes sample processing with a unique design.

Pharmaceutical 52

Pharmaceutical 52

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

PharmaTech

MARCH 29, 2024

Can Cellares deliver on the goal to meet total patient demand for cell therapies globally? CEO Fabian Gerlinghaus discusses.

Patients 59

Patients 59

Pharmaceutical Technology

MARCH 29, 2024

Discover how Crinetics Pharmaceuticals Inc's patent for compounds modulating somatostatin activity can suppress hormone secretion in mammals. Explore the detailed framework for hormone modulation and SSTR2 activity regulation.

Pharmaceutical 52

Pharmaceutical 52

Pharmaceutical Commerce

MARCH 29, 2024

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Management 52

Management Pharmaceutical 52

Pharmaceutical Technology

MARCH 29, 2024

Expand transplantable NK cell fractions for cancer treatment with Gamida Cell's patented method. Culturing, supplementing, and storing cells ensure improved outcomes for cancer patients.

Patients 52

Patients 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

PharmExec

MARCH 29, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Patients 52

Patients FDA 52

Pharmaceutical Technology

MARCH 29, 2024

Discover Rohto Pharmaceutical's patented ophthalmic composition with crocetin and ginkgo leaf extract, proven to prevent and treat myopia in all ages. Explore the groundbreaking method for treating axial myopia and ocular diseases.

Pharmaceutical 52

Pharmaceutical 52

PharmExec

MARCH 29, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Technology

MARCH 29, 2024

Revolutionize your labeling process with Angelini Spa's patented method using a robot and label printer to efficiently attach printed labels to reels. Patent Publication Number: US11884443B2.

52

52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management